$IMAX

Orbis and Allan Gray (IMAX) disclose 5.15M IMAX shares, a 9.4% beneficial stake

Orbis Investment Management Limited and Allan Gray Australia Pty Ltd filed a Schedule 13G/A for IMAX Corp common stock, reporting combined beneficial ownership of 5,149,555 shares, or 9.4% of the outstanding class. Orbis has sole voting and dispositive power over 5,129,735 shares, Allan Gray over 19,820 shares.

Original reporting
Published Aug 14, 2026, 5:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 9:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$IMAX
Neutral
medium confidence
Mentioned
$IMAX
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$IMAXNeutralLow
01

Why it matters

The key new information is the reported aggregate beneficial ownership (5,149,555 shares, 9.4%) and the split of sole voting and dispositive power between the two reporting persons.

02

Market read

This is a shareholder-structure update that may matter for governance expectations, but it does not include a fundamental catalyst.

03

What to watch

Traders may overreact to the 9.4% figure; without changes in voting plans, board actions, or a 13D conversion, the immediate trading signal is weak.

Relevance 4/10Novelty 4/10Timing: filing disclosed on 2026-08-14

Background

The article summarizes a Schedule 13G/A style disclosure of beneficial ownership by Orbis Investment Management Limited and Allan Gray Australia Pty Ltd.

Company-level read

Ticker impact

$IMAXNeutralMedium confidence
Context

Orbis Investment Management and Allan Gray Australia disclosed beneficial ownership of 5.15M IMAX shares, about 9.4% of the float.

Expected impact

Likely limited near-term impact; any effect would be indirect via perceived governance influence rather than fundamentals.

Evidence & confidence

The article provides ownership size and voting/dispositive power details, with no accompanying deal, financing, or business change.

Market effects

Minimal, since the disclosure is company-specific ownership concentration rather than a sector-wide signal.

Minimal, as the holders are non-U.S. institutions but the impact is confined to IMAX’s shareholder base.

Low, no cross-border transaction or regulatory action is described.

Counterpoint

Large beneficial ownership can be a precursor to activism or strategic moves, but this filing alone does not confirm intent beyond reporting requirements.

Key entities

  • IMAX Corp

    Beneficiary of the ownership disclosure; the filing reports 5.15M shares and 9.4% beneficial ownership by Orbis and Allan Gray Australia.

  • Orbis Investment Management Limited

    Reports sole voting and dispositive power over 5,129,735 IMAX shares.

  • Allan Gray Australia Pty Ltd

    Reports sole voting and dispositive power over 19,820 IMAX shares.

Related articles

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.

$IMAXMed

'The Odyssey' fuels Imax stock to all-time high. CEO calls momentum a 'flywheel'

Imax shares hit an all-time high Monday, up nearly 6%, after box office momentum from Christopher Nolan’s “The Odyssey.” The company said the film is tracking almost double “Oppenheimer” (2023) and generated $221 million globally, about 25% of Universal’s total. CEO Rich Gelfond attributed results to a “flywheel” of theater expansion and recurring cash flow.